Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M72,123Revenue $M7,238Net Margin (%)21.1Altman Z-Score11.6
Enterprise Value $M69,324EPS $5.0Operating Margin %27.8Piotroski F-Score7
P/E(ttm)47.9Beneish M-Score-2.6Pre-tax Margin (%)27.5Higher ROA y-yY
Price/Book9.210-y EBITDA Growth Rate %16.1Quick Ratio4.2Cash flow > EarningsY
Price/Sales10.15-y EBITDA Growth Rate %24.9Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow44.2y-y EBITDA Growth Rate %10.8ROA % (ttm)13.5Higher Current Ratio y-yY
Dividend Yield %0.1PEG1.9ROE % (ttm)21.9Less Shares Outstanding y-yN
Payout Ratio %4.0Shares Outstanding M300ROIC % (ttm)30.5Gross Margin Increase y-yY

Gurus Latest Trades with AGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGNBill Ackman 2015-03-31 Sold Out -35.3%$209.37 - $240.22
($225.95)
$ 240.226%Sold Out0
AGNJohn Paulson 2015-03-31 Sold Out -7%$209.37 - $240.22
($225.95)
$ 240.226%Sold Out0
AGNGeorge Soros 2015-03-31 Sold Out -1.1%$209.37 - $240.22
($225.95)
$ 240.226%Sold Out0
AGNFirst Eagle Investment 2015-03-31 Sold Out -0.33%$209.37 - $240.22
($225.95)
$ 240.226%Sold Out0
AGNMario Gabelli 2015-03-31 Sold Out -0.077%$209.37 - $240.22
($225.95)
$ 240.226%Sold Out0
AGNKen Fisher 2015-03-31 Sold Out -0.0026%$209.37 - $240.22
($225.95)
$ 240.226%Sold Out0
AGNJoel Greenblatt 2015-03-31 Sold Out -0.0016%$209.37 - $240.22
($225.95)
$ 240.226%Sold Out0
AGNDodge & Cox 2015-03-31 Sold Out -0.0006%$209.37 - $240.22
($225.95)
$ 240.226%Sold Out0
AGNBill Ackman 2014-12-31 Reduce-2.98%$176.86 - $214
($199.35)
$ 240.2221%Reduce 7.77%26,635,978
AGNGeorge Soros 2014-12-31 Buy 1.1%$176.86 - $214
($199.35)
$ 240.2221%New holding494,786
AGNJohn Paulson 2014-12-31 Add1.09%$176.86 - $214
($199.35)
$ 240.2221%Add 18.46%6,370,000
AGNFirst Eagle Investment 2014-12-31 Add0.32%$176.86 - $214
($199.09)
$ 240.2221%Add 6244.76%634,476
AGNMario Gabelli 2014-12-31 Reduce-0.05%$176.86 - $214
($199.09)
$ 240.2221%Reduce 43.70%69,780
AGNJoel Greenblatt 2014-12-31 Reduce-0.01%$176.86 - $214
($199.35)
$ 240.2221%Reduce 83.33%945
AGNJohn Paulson 2014-09-30 Reduce-0.16%$151.92 - $179.7
($165.84)
$ 240.2245%Reduce 4.01%5,377,200
AGNJoel Greenblatt 2014-09-30 Reduce-0.02%$151.92 - $179.7
($165.84)
$ 240.2245%Reduce 65.17%5,670
AGNFirst Eagle Investment 2014-09-30 Reduce-0.01%$151.92 - $179.7
($165.84)
$ 240.2245%Reduce 66.67%10,000
AGNBill Ackman 2014-06-30 Add38%$116.63 - $173.95
($155.63)
$ 240.2254%Add 4733.79%28,878,538
AGNJohn Paulson 2014-06-30 Buy 4.1%$116.63 - $173.95
($155.63)
$ 240.2254%New holding5,602,000
AGNFirst Eagle Investment 2014-06-30 Buy 0.01%$116.63 - $173.95
($155.63)
$ 240.2254%New holding30,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hindman James M.EVP, Finance & Bus. Dev., CFO 2014-08-18Sell0$0view
Sherman Scott DExecutive Vice President, HR 2014-04-22Sell14,500$155.8254.17view
LAVIGNE LOUIS J JRDirector 2014-02-21Sell5,400$125.7990.97view
INGRAM DOUGLAS SPresident 2014-02-21Sell1$125.791.11view
HUDSON DAWN EDirector 2014-02-19Sell4,200$126.3590.12view
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFO 2014-02-19Sell38,900$126.3990.06view
Diradoorian Raymond HEVPGlobal Technical Operations 2014-02-19Sell23,000$126.6689.66view
Sherman Scott DExecutive Vice President, HR 2014-02-18Sell5,001$125.7491.05view
INGRAM DOUGLAS SPresident 2014-02-14Sell84,000$124.493.1view
BARLOW JAMES FSR. VP, Corp. Controller (PAO) 2014-02-12Sell23,875$123.5294.48view

Press Releases about AGN :

    Quarterly/Annual Reports about AGN:

      News about AGN:

      Articles On GuruFocus.com
      Actavis Stock – A Must Have For Long-Term Investors May 27 2015 
      Pioneer Investments Sells Stakes in Allergan, Xilinx in First Quarter May 15 2015 
      Valeant Finally Bags Salix for $11 Billion Apr 06 2015 
      Pershing Square Holdings: First Annual Report Mar 25 2015 
      Ruane, Cunniff & Goldfarb Inc Comments on Valeant Mar 16 2015 
      personal Mar 09 2015 
      Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals Feb 24 2015 
      Weekly 52-Week Highs Highlight: DG, AGN, ADSK, AVGO, PCYC Feb 22 2015 
      John Paulson's Top Buys Feb 21 2015 
      A Look at Larry Robbins and His Latest Portfolio Update Feb 20 2015 

      More From Other Websites
      Valeant closes $11B deal for Raleigh's Salix Pharmaceuticals Apr 01 2015
      Salix had a $13B offer on the table before accounting problems crashed share price Mar 24 2015
      Talking Allergan at Tulane: a 'Horse Choker,' the 'Shamarendum' and More Mar 24 2015
      ALLERGAN INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of... Mar 18 2015
      Sale of Allergan to Actavis is finalized; CEO David Pyott stepping down Mar 17 2015
      Actavis' Depression Drug Gains FDA Approval for New Dose - Analyst Blog Mar 17 2015
      Cramer: Market cross currents Mar 17 2015
      Valeant (VRX) Raises Salix Offer, Endo Withdraws Proposal - Analyst Blog Mar 17 2015
      Allergan sale complete, CEO Pyott steps down Mar 17 2015
      American Airlines Group (AAL) to Enter Coveted S&P 500 - Analyst Blog Mar 17 2015
      Allergan sale to Actavis complete; CEO David Pyott is leaving Mar 17 2015
      Pharma Stock Outlook: Let's Make a Deal - Industry Outlook Mar 17 2015
      Pharma Stock Outlook: Let's Make a Deal - Zacks Analyst Interviews Mar 17 2015
      Actavis Completes Acquisition of Allergan Mar 17 2015
      American Airlines Joining The S&P 500, Analysts Bullish On U.S. Skies Mar 17 2015
      Cramer's Stop Trading: ESPR Mar 17 2015
      Actavis says Allergan's Pyott won't join new company's board Mar 17 2015
      American Airlines Replaces Allergan in S&P 500 Mar 17 2015
      Actavis Completes Allergan Acquisition Mar 17 2015
      Cramer's Mad Dash: ACT & MGM Mar 17 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK